Understanding and Communicating the Benefits and Risks of Denosumab, Raloxifene, and Teriparatide for the Treatment of Osteoporosis-Reference-Cited by-同舟云学术

Understanding and Communicating the Benefits and Risks of Denosumab, Raloxifene, and Teriparatide for the Treatment of Osteoporosis

Published:2014-10 Issue:4 Volume:17 Page:490-495
ISSN:1094-6950
Container-title:Journal of Clinical Densitometry
language:en
Short-container-title:Journal of Clinical Densitometry

Author:

Lewiecki E. Michael,Miller Paul D.,Harris Steve T.,Bauer Douglas C.,Davison K. Shawn,Dian Larry,Hanley David A.,McClung Michael R.,Yuen Chui K.,Kendler David L.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference41 articles.

1. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis;MacLean;Ann Intern Med,2008

2. Recognition of osteoporosis by primary care physicians;Gehlbach;Am J Public Health,2002

3. Underuse of osteoporosis medications in elderly patients with fractures;Solomon;Am J Med,2003

4. A systematic review of persistence and compliance with bisphosphonates for osteoporosis;Cramer;Osteoporos Int,2007

5. Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem;Cramer;Am J Med,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cell-Penetrating Peptide GV1001 Enhances Bone Formation via Pin1-Mediated Augmentation of Runx2 and Osterix Stability;Biomolecules;2024-07-08

2. Special Considerations to Improve Clinical Outcomes in Patients with Osteoporosis Undergoing Spine Surgery;International Journal of Spine Surgery;2021-04

3. Posttransplantation bone disease: prevalence, surveillance, prevention, and management;Blood and Marrow Transplantation Long Term Management;2021-03-19

4. Recent development of drugs for osteoporosis and anti-cancer agents: a patent analysis;Pharmaceutical Patent Analyst;2021-03

5. Safety Considerations for Osteoporosis Therapies;Osteoporosis;2020